FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry and is a spray for the emergency prevention of acute respiratory viral infections, containing water, characterized in that it contains sodium chloride and sodium hypochlorite solution with pH equal to 8.0–10.0, an active chlorine concentration of 0.30–0.60 mg/l and a droplet size of 90–110 mcm, the spray components are in a certain ratio, in wt. %.
EFFECT: invention provides increased effectiveness of ARVI prophylaxis, expressed in preventing the disease during epidemics, reduced severity of the disease, reduced number of complications in patients who are provided with the virucidal action of the proposed drug, the ability to increase local immunity of mucous membranes, the ability to activate oxidative processes in tissues.
1 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR TREATING ORAL CANDIDIASIS | 2021 |
|
RU2780094C1 |
DRUG WITH SPASMOLITHIC, DIURETIC AND LITHIOLIC ACTION | 2017 |
|
RU2635459C1 |
ANTISPASMODIC, ANTIULCER AND ANTACID AGENT | 2021 |
|
RU2784057C1 |
DRUG WITH LITHOLITHIC, DIURETIC AND ANTI-INFLAMMATORY ACTION | 2017 |
|
RU2635196C1 |
COMPOSITION FOR TOPICAL APPLICATION IN THE TREATMENT OF ONYCHOMYCOSIS (OPTIONS) | 2022 |
|
RU2786851C1 |
ANTI-INFLAMMATORY DIMEXID GEL | 2008 |
|
RU2408366C2 |
DIMEXIDE GEL POSSESSING ANTI-INFLAMMATORY ACTION | 2024 |
|
RU2838731C1 |
ANTI-VIRAL IMMUNOTROPIC AGENT FOR TREATMENT OF ARVI | 2018 |
|
RU2672888C1 |
COMPOSITION FOR TREATMENT AND PREVENTION OF DISEASES OF UPPER RESPIRATORY TRACT IN FORM OF NASAL SPRAY | 2024 |
|
RU2839143C1 |
ANTISPASMODIC, DIURETIC AND ANTI-INFLAMMATORY DRUG (VERSIONS) | 2024 |
|
RU2836881C1 |
Authors
Dates
2018-09-05—Published
2017-11-21—Filed